Suppr超能文献

miR-1246:p53 家族与癌症和唐氏综合征的新联系。

MiR-1246: a new link of the p53 family with cancer and Down syndrome.

机构信息

Department of Biochemistry & Molecular Biology and Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA.

出版信息

Cell Cycle. 2012 Jul 15;11(14):2624-30. doi: 10.4161/cc.20809.

Abstract

Since the discovery of miRNAs, a number of miRNAs have been identified as p53's transcriptional targets. Most of them are involved in regulation of the known p53 functions, such as cell cycle, apoptosis and senescence. Our recent study revealed miR-1246 as a novel target of p53 and its analogs p63 and p73 to suppress the expression of DYRK1A and consequently activate NFAT, both of which are associated with Down syndrome and possibly with tumorigenesis. This finding suggests that miR-1246 might serve as a likely link of the p53 family with Down syndrome. Here, we provide some prospective views on the potential role of the p53 family in Down syndrome via miR-1246 and propose a new p53-miR-1246-DYRK1A-NFAT pathway in cancer.

摘要

自 miRNA 被发现以来,已有许多 miRNA 被鉴定为 p53 的转录靶标。其中大多数参与调节已知的 p53 功能,如细胞周期、细胞凋亡和衰老。我们最近的研究揭示了 miR-1246 作为 p53 及其类似物 p63 和 p73 的一个新靶标,可抑制 DYRK1A 的表达,进而激活 NFAT,两者都与唐氏综合征有关,并且可能与肿瘤发生有关。这一发现表明,miR-1246 可能是 p53 家族与唐氏综合征之间的一个可能的联系。在这里,我们通过 miR-1246 提供了一些关于 p53 家族在唐氏综合征中的潜在作用的前瞻性观点,并提出了癌症中 p53-miR-1246-DYRK1A-NFAT 新途径。

相似文献

1
MiR-1246: a new link of the p53 family with cancer and Down syndrome.
Cell Cycle. 2012 Jul 15;11(14):2624-30. doi: 10.4161/cc.20809.
2
p53 downregulates Down syndrome-associated DYRK1A through miR-1246.
EMBO Rep. 2011 Jun 3;12(8):811-7. doi: 10.1038/embor.2011.98.
3
Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
J Biol Chem. 2010 Oct 8;285(41):31895-906. doi: 10.1074/jbc.M110.147520. Epub 2010 Aug 9.
4
p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.
Oncol Rep. 2015 Mar;33(3):1335-41. doi: 10.3892/or.2015.3715. Epub 2015 Jan 14.
5
DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis.
Cell Mol Life Sci. 2021 Jan;78(2):603-619. doi: 10.1007/s00018-020-03626-4. Epub 2020 Sep 1.
7
DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.
J Biol Chem. 2010 Apr 23;285(17):13223-32. doi: 10.1074/jbc.M110.102574. Epub 2010 Feb 18.
8
Mdm2: p53's lifesaver?
Mol Cell. 2007 Mar 23;25(6):794-6. doi: 10.1016/j.molcel.2007.03.006.
9
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
Cancer Metastasis Rev. 2010 Dec;29(4):613-39. doi: 10.1007/s10555-010-9257-9.
10
Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
J Biol Chem. 2011 Nov 18;286(46):40401-12. doi: 10.1074/jbc.M111.253971. Epub 2011 Sep 30.

引用本文的文献

3
A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.
Int J Mol Sci. 2024 Dec 16;25(24):13468. doi: 10.3390/ijms252413468.
4
Advanced Analysis and Validation of a microRNA Signature for Fanconi Anemia.
Genes (Basel). 2024 Jun 21;15(7):820. doi: 10.3390/genes15070820.
5
Identification of circulating miRNAs as fracture-related biomarkers.
PLoS One. 2024 May 31;19(5):e0303035. doi: 10.1371/journal.pone.0303035. eCollection 2024.
7
Novel potential therapeutic targets of alopecia areata.
Front Immunol. 2023 Apr 19;14:1148359. doi: 10.3389/fimmu.2023.1148359. eCollection 2023.
10
miR profile in pagetic osteoclasts: from large-scale sequencing to gene expression study.
J Mol Med (Berl). 2021 Dec;99(12):1771-1781. doi: 10.1007/s00109-021-02128-5. Epub 2021 Oct 5.

本文引用的文献

2
microRNA-34a regulates neurite outgrowth, spinal morphology, and function.
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21099-104. doi: 10.1073/pnas.1112063108. Epub 2011 Dec 12.
3
p53-Dependent induction of PVT1 and miR-1204.
J Biol Chem. 2012 Jan 20;287(4):2509-19. doi: 10.1074/jbc.M111.322875. Epub 2011 Nov 22.
4
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.
Nucleic Acids Res. 2012 Jan;40(2):499-510. doi: 10.1093/nar/gkr731. Epub 2011 Sep 14.
5
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma.
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15840-5. doi: 10.1073/pnas.1019312108. Epub 2011 Sep 6.
6
microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects.
Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1519-30. doi: 10.1152/ajpheart.01080.2010. Epub 2011 Aug 12.
7
Autoregulatory suppression of c-Myc by miR-185-3p.
J Biol Chem. 2011 Sep 30;286(39):33901-9. doi: 10.1074/jbc.M111.262030. Epub 2011 Aug 8.
8
DYRK1A binds to an evolutionarily conserved WD40-repeat protein WDR68 and induces its nuclear translocation.
Biochim Biophys Acta. 2011 Oct;1813(10):1728-39. doi: 10.1016/j.bbamcr.2011.06.023. Epub 2011 Jul 13.
9
p53 downregulates Down syndrome-associated DYRK1A through miR-1246.
EMBO Rep. 2011 Jun 3;12(8):811-7. doi: 10.1038/embor.2011.98.
10
Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome.
Cancer Res. 2011 May 15;71(10):3573-81. doi: 10.1158/0008-5472.CAN-10-4489. Epub 2011 Apr 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验